Sponsors
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Blog
Chairman, GDS International
Sales and the 'Talent Magnet'
A lot is written about being a ‘Talent Magnet’, either as a company, or as President. It’s all good practice – listen, mentor, reward, provide clear goals and career maps. Good practice for the employer, but what about the employee?26 May 2011
White Papers
Focus Area: Drug Discovery
A Targeted Approach
Scott Clark of Gentris Clinical Genetics, Inc. tells NGP why microarray technology is proving beneficial for drug discovery.
Gearing up for Battle
Novartis Vaccines’ CEO Andrin Oswald tells NGP how the company is preparing for the next wave of H1N1 mutations, and why a new manufacturing process is needed to provide faster vaccinations.
Economies of Scales
The benefits of essential fatty acids have long been established, but introducing them into the pharmaceutical sphere is a relatively recent phenomenon. Hilda Steineger explains how Pronova’s use of omega-3 from fish oil has transformed an age-old remedy into a potential blockbuster.
Rapid assay development for protein biomarkers
NextGen Sciences’ platform is a solution that greatly shortens the assay development time relative to more conventional platforms such as immunoassays.
The Challenges of Biomarkers
The implementation of biomarkers for patient stratification to improve oncology-targeted therapies is still an extremely challenging endeavor with limited success. By Peter Duncan, Definiens AG
Source: www.ngpharma.com© 2012 GDS Publishing Ltd. All rights reserved.